Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

More muscle needed for regulatory science …

Thursday, September 17th, 2009

Or all the billions of dollars poured into biomedical research and development in the U.S. won’t mean a thing. That was the prevailing message delivered yesterday by new FDA commissioner Margaret Hamburg during a candid keynote address at the Regulator Affairs Professionals Society’s annual conference in Philadelphia. “In order to strengthen ...

   
©2012 UBM Canon